Can Advanced Endoscopic Imaging Help Us Avoid Surgery for Endoscopically Resectable Colorectal Neoplasms? A Proof-of-Concept Study.


Journal

Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782

Informations de publication

Date de publication:
06 2020
Historique:
received: 11 07 2019
accepted: 03 10 2019
pubmed: 21 10 2019
medline: 21 10 2020
entrez: 21 10 2019
Statut: ppublish

Résumé

European guidelines recommend advanced endoscopic imaging (AEI) to guide therapeutic decisions; however, data are limited concerning its clinical effects on the management of colorectal polyps. The aim of this study was to investigate the effect of standard chromoendoscopic imaging (SCI) and AEI on decision-making regarding therapeutic techniques. We retrospectively analyzed prospectively collected endoscopic and pathological data on colorectal neoplasms ≥ 10 mm removed at a Japanese tertiary cancer center between January 2010 and December 2016. We assumed a virtual approach to manage the decisions for endoscopic resection or surgery for each lesion using the following test modalities: (1) endoscopic size measurement (ESM), (2) SCI, and (3) AEI. Virtual surgical management was indicated using the following criteria: (1) ESM: lesion ≥ 40 mm, (2) SCI: depression, excavation, or ulceration, (3) AEI: Japan NBI Expert Team type 3 (magnifying NBI), V A total of 3509 lesions from 2693 patients were analyzed, including 142 SM-S and 457 deep submucosal invasive cancer (SM-D). The incidence of hypothetical redundant surgery was 9.2% with ESM, 5.1% with SCI, and 2.9% with AEI. When compared with ESM, hypothetical redundant surgery was significantly reduced with SCI (relative risk 0.55; 95% confidence interval 0.44-0.69) and AEI (0.31; 0.23-0.41). Therapeutic decision-making according to SCI or AEI can reduce surgery for endoscopically resectable colorectal neoplasms.

Sections du résumé

BACKGROUND
European guidelines recommend advanced endoscopic imaging (AEI) to guide therapeutic decisions; however, data are limited concerning its clinical effects on the management of colorectal polyps. The aim of this study was to investigate the effect of standard chromoendoscopic imaging (SCI) and AEI on decision-making regarding therapeutic techniques.
METHODS
We retrospectively analyzed prospectively collected endoscopic and pathological data on colorectal neoplasms ≥ 10 mm removed at a Japanese tertiary cancer center between January 2010 and December 2016. We assumed a virtual approach to manage the decisions for endoscopic resection or surgery for each lesion using the following test modalities: (1) endoscopic size measurement (ESM), (2) SCI, and (3) AEI. Virtual surgical management was indicated using the following criteria: (1) ESM: lesion ≥ 40 mm, (2) SCI: depression, excavation, or ulceration, (3) AEI: Japan NBI Expert Team type 3 (magnifying NBI), V
RESULTS
A total of 3509 lesions from 2693 patients were analyzed, including 142 SM-S and 457 deep submucosal invasive cancer (SM-D). The incidence of hypothetical redundant surgery was 9.2% with ESM, 5.1% with SCI, and 2.9% with AEI. When compared with ESM, hypothetical redundant surgery was significantly reduced with SCI (relative risk 0.55; 95% confidence interval 0.44-0.69) and AEI (0.31; 0.23-0.41).
CONCLUSIONS
Therapeutic decision-making according to SCI or AEI can reduce surgery for endoscopically resectable colorectal neoplasms.

Identifiants

pubmed: 31630341
doi: 10.1007/s10620-019-05894-y
pii: 10.1007/s10620-019-05894-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1829-1837

Auteurs

Kazuya Hosotani (K)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Kenichiro Imai (K)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan. k.imai1977@gmail.com.

Kinichi Hotta (K)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Sayo Ito (S)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Yoshihiro Kishida (Y)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Masao Yoshida (M)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Noboru Kawata (N)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Naomi Kakushima (N)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Kohei Takizawa (K)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Hirotoshi Ishiwatari (H)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Hiroyuki Matsubayashi (H)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Hiroyuki Ono (H)

Division of Endoscopy, Shizuoka Cancer Center, 1007, Shimonagakubo, Nagaizumi-cho, Suntogun, Shizuoka, 411-8777, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH